Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

FPA Source Capital 2026 Q3 Investor Letter | Buyside Digest

Back to Fund Profile (FPA Source Capital)

Primary Source Intelligence • Q3 2026 Letter Analysis

FPA Source Capital Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, FPA Source Capital. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD+1.86%

YTD+7.14%

Annualized+8.46%

Positioning StanceCONSTRUCTIVE

Market CapAll Cap

GeographyUS, Global

Digest Analysis

Quick Take

"Rapidly climbing interest rates are creating compelling yields across short-term Treasuries and TIPS, while tight corporate credit spreads signal looming stress that may soon unlock distressed debt opportunities."

Executive Summary

Source Capital delivered a net asset value return of 1.86% net of fees for the third quarter of 2026 and 11.71% net of fees for the trailing twelve months, outpacing its illustrative balanced benchmark of 60% MSCI ACWI / 40% Bloomberg US Aggregate (which returned -0.46% for the quarter and 9.15% over twelve months). The closed-end fund maintained a balanced asset allocation posture, deploying 47.8% into common equities, 31.5% across credit instruments (composed of 7.4% public debt and 24.1% invested private credit), 3.9% in limited partnerships, and 15.8% in cash and cash equivalents. The fund continues to expand its private credit exposure, which grew 3.1 percentage points during the quarter. Management highlighted that a rising interest rate environment opened up attractive opportunities to acquire short-term U.S. Treasuries yielding near 5%, while also prompting a new allocation to Treasury Inflation-Protected Securities yielding above 3% on a real basis. In corporate debt, high-yield spreads widened slightly during the quarter—led by lower-rated issues—though BB spreads excluding energy remain compressed by historical standards. The managers cautioned that the rapid ascent in interest rates could eventually induce distress in corporate credit markets, creating potential opportunities for disciplined redeployment. Within the equity sleeve, the fund selectively trimmed winners tied to artificial intelligence while establishing new positions in healthcare via Boston Scientific and HCA Healthcare, alongside domestic and international small- and mid-cap additions including Core & Main and JBT Marel. Key positive trailing contributors included Analog Devices, Alphabet, Samsung C&T, and Glencore, whereas broadband operators Charter Communications and Comcast detracted amid intensified competitive pressures from fixed wireless and fiber overbuilders.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

58%

CautiousHigh

Moderate (58%)

The portfolio maintains a balanced multi-asset mandate spanning public equities, private credit, and government paper, distributing capital across multiple distinct asset sleeves rather than concentrating heavily in single equity names. Position weights in top equities range between 0.2% and 3.6%, reflecting prudent diversification alongside deliberate additions to new sectors like healthcare and SMIDs.

Growth Outlook

55%

BearishBullish

Neutral (55%)

Management expresses a balanced view of broader asset markets, highlighting attractive real yields in government bonds alongside AI-driven earnings momentum, while warning that elevated rates could cause stress in corporate credit. Equity exposures are kept around 48% with healthy cash and private credit allocations ready for deployment.

Risk Appetite

52%

DefensiveAggressive

Balanced (52%)

Positioning remains balanced between equities and credit, supported by a 15.8% cash and equivalent cushion and an emphasis on short-term Treasuries and TIPS. Risk-taking is largely focused on increasing private credit exposure to 24.1% rather than chasing extended equity valuations.

Capital Deployment

60%

De-riskingDeploying

Net Neutral (60%)

Capital deployment is active but measured, with exposure added to private credit (up 3.1%), new equity positions initiated in healthcare and SMIDs, and cash allocated into attractive Treasury and TIPS paper.

Forward Guidance

65%

CautiousExpansionary

Expansionary (65%)

The managers are actively building new equity positions at sensible valuations while intending to expand private credit allocations over time. They explicitly note readiness to capitalize on emerging distress in corporate debt markets as rising rates take effect.

Language Signal

58%

BearishBullish

Balanced (58%)

Commentary reflects a healthy balance of constructive language regarding fundamental performance at portfolio companies and cautious observations concerning tight credit spreads and broadband competition.

Perceived Risk

58%

Low RiskElevated

Moderate Risk (58%)

The management team identifies elevated interest rates as a primary catalyst for potential stress across corporate credit markets, alongside heightened competitive pressure and leverage risks in specific sectors such as broadband.

Opportunity Density

60%

ScarceAbundant

Selective (60%)

Compelling risk-adjusted opportunities are identified selectively within high-yielding short Treasuries, real return TIPS, private credit, and specific healthcare and SMID equities, though tight corporate bond spreads limit broad fixed-income bargains.

Time Horizon

75%

Short-TermLong-Term

Decade+ (75%)

Investment discussions emphasize multi-year fundamental compounding across business cycles and long-term asset value realization, such as holding company discounts and corporate integration timelines.